Oral contraceptives for functional ovarian cysts
reference-entry
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
Combined oral contraceptives were found to offer no benefit in hastening the resolution of functional ovarian cysts compared to watchful waiting.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Functional ovarian cysts are a common gynecological problem among women of reproductive age worldwide. When large, persistent, or painful, these cysts may require operations, sometimes resulting in removal of the ovary. Since early oral contraceptives were associated with a reduced incidence of functional ovarian cysts, many clinicians inferred that birth control pills could be used to treat cysts as well. This became a common clinical practice in the early 1970s. OBJECTIVES: This review examined all randomized controlled trials that studied oral contraceptives as therapy for functional ovarian cysts. SEARCH STRATEGY: We searched the computer databases of CENTRAL, PubMed, POPLINE, and EMBASE for randomized controlled trials. We also examined the reference lists of articles and wrote to authors of all studies identified to seek articles we had missed. SELECTION CRITERIA: We included randomized controlled trials in any language that included oral contraceptives used for treatment and not prevention of functional ovarian cysts. Criteria for diagnosis of cysts were those used by authors of studies. DATA COLLECTION AND ANALYSIS: Two authors independently abstracted data from the articles and entered them into RevMan 4.2. We used Peto odds ratios with 95% confidence intervals for dichotomous outcomes. MAIN RESULTS: We identified four randomized controlled trials from three countries; the studies included a total of 227 women. Treatment with combined oral contraceptives did not hasten resolution of functional ovarian cysts in any trial. This held true for cysts that occurred spontaneously as well as those that developed after ovulation induction. Most cysts resolved without treatment within a few cycles; persistent cysts tended to be pathological (e.g., endometrioma or para-ovarian cyst) and not physiological. AUTHORS' CONCLUSIONS: Although widely used for treating functional ovarian cysts, combined oral contraceptives appear to be of no benefit. Watchful waiting over several cycles is appropriate. Should cysts persist, surgical management is often indicated.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (36)
- Detection and management of pathological, non-palpable, cystic adnexal masses via openalex
- Functional ovarian cysts in premenopausal and gynecologically healthy women via openalex
- Is hormonal suppression efficacious in treating functional ovarian cysts? via openalex
- Oral Contraceptive Use and Benign Gynecologic Conditions via openalex
- Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: A prospective, randomized trial via openalex
- Should OCs be prescribed to prevent adnexal masses? via openalex
- Therapeutic uses of contraceptive steroids. via openalex
- Zur Rückbildung funktioneller Zysten: Hochdosierte Ovulationshemmer und Gestagentherapie ohne zusätzlichen Effekt via openalex
- W2435388170 via openalex
- W2916934990 via openalex
- W6638660473 via openalex
- W6718214484 via openalex
- W6758963077 via openalex
- doi:10.1001/jama.1974.03230260042022 via openalex
- doi:10.1111/j.1471-0528.1992.tb13733.x via openalex
- doi:10.1093/oxfordjournals.humrep.a019269 via openalex
- doi:10.1093/humrep/16.7.1527 via openalex
- doi:10.1016/s0002-9378(11)91570-1 via openalex
- doi:10.1097/00129689-200102000-00001 via openalex
- doi:10.3109/09513599509160463 via openalex
- doi:10.1023/a:1020381310860 via openalex
- doi:10.3109/00016349309021121 via openalex
- doi:10.1016/0020-7292(94)90570-3 via openalex
- doi:10.1136/jech.46.5.528 via openalex
- doi:10.1016/0002-9378(92)91371-g via openalex
- doi:10.1089/gyn.1996.12.21 via openalex
- doi:10.1016/0010-7824(95)00096-s via openalex
- doi:10.1016/s0015-0282(16)53930-2 via openalex
- doi:10.1097/00001648-199609000-00019 via openalex
- doi:10.1093/humrep/15.12.2567 via openalex
- W1828803388 via openalex
- doi:10.1016/0002-9378(73)90913-7 via openalex
- doi:10.1136/bmj.294.6586.1518 via openalex
- W2287389390 via openalex
- W2414807215 via openalex
- W2417196963 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-14T06:07:48.142452+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK